Watch the latest episode of focusIR Fireside Chats: Why Edinburgh Investment Trust Is Backing Turnaround Stocks for 2026 Growth. View here

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksNext Regulatory News (NXT)

Share Price Information for Next (NXT)

Share Price is delayed by 15 minutes
Get Live Data
14,615.00    -100.00 (-0.68%)
Bid:
14,620.00
Ask:
14,630.00
Spread: 10.00 (0.068%)
Market Cap: £16.68b
NXT Live PriceLast checked at - London Stock Exchange

Intraday Next Share Chart

Director/PDMR Shareholding

3 Oct 2025 16:45

RNS Number : 0707C
Next PLC
03 October 2025
 

3 October 2025

NEXT plc

Notification of Transactions by Persons Discharging Managerial Responsibilities and Persons Closely Associated with Them (PCA)

The following awards were granted to executive directors and a PCA on 3 October 2025 under the NEXT Long Term Incentive Plan (the "LTIP"):

Maximum No. of Shares

Lord Wolfson of Aspley Guise

8,776

Jonathan Blanchard

5,575

Richard Papp

6,504

Jane Shields

6,504

Jeremy Stakol

5,575

Marcelle Stakol (PCA)

1,014

Under the terms of each LTIP the award comprises a conditional award of shares on the following terms:

·

the award will vest following the third anniversary of the date of grant subject to performance targets and continued employment in the NEXT Group;

 

·

a variable percentage of the maximum number of shares above can vest, depending on the relative Total Shareholder Return of NEXT over a three year period against a comparator group;

 

·

for relative performance against the comparator group the percentage vesting will be:

 

Relative performance

Percentage vesting

Below median

0%

Median

20%

Upper quintile

100%

 

·

the Remuneration Committee has discretion to override and reduce formulaic outcomes under the LTIP awards should this be considered appropriate in the circumstances;

 

·

before any of the awards vest, the Committee must have regard to the underlying financial performance of the Company;

 

·

to the extent that the performance condition is not met, the award will lapse completely;

 

·

to the extent that awards vest, dividend equivalents will be accrued; and

 

·

any vesting of these awards granted (including dividend equivalents) will be settled in shares and, after payment of tax, the net shares received should be retained by executive directors for a period of two further years and PCAs for a further period of 6 months.

 

LTIP awards are made twice a year. The maximum number of shares shown above is 112.5% of each executive director's (60% of PCA's) base salary at the date of grant, divided by NEXT's average share price over the three months prior to the start of the performance period.

The following notification is made in accordance with article 19 of the UK Market Abuse Regulation ("MAR") and relates to awards granted to executive directors and a PCA on 3 October 2025 under the LTIP.

1

 

Details of the person discharging managerial responsibilities ("PDMR") / person closely associated ("PCA")

a)

 

Name

 

1. Lord Wolfson of Aspley Guise

2. Jonathan Blanchard

3. Richard Papp

4. Jane Shields

5. Jeremy Stakol

6. Marcelle Stakol

 

2

Reason for the notification

a)

 

Position/status

 

1. Chief Executive (PDMR)

2. Chief Financial Officer (PDMR)

3. Group Merchandise and Operations Director (PDMR)

4. Group Sales, Marketing and HR Director (PDMR)

5. Group Investments, Acquisitions and Third Party Brands Director (PDMR)

6. Brand Director (PCA with Jeremy Stakol)

 

b)

Initial notification /Amendment

Initial notification

3

 

Details of the issuer, emission allowance market participant, auction platform, auctioneer or auction monitor

a)

Name

NEXT plc

b)

 

LEI

213800WQD8ECPZP9PH98

4

 

Details of the transaction(s): section to be repeated for (i) each type of instrument; (ii) each type of transaction; (iii) each date; and (iv) each place where transactions have been conducted

a)

 

Description of the financial instrument, type of instrument

Ordinary shares of £0.10 each - conditional award

Identification code

GB0032089863

b)

 

Nature of the transaction

 

 

 

 

 

 

 

 

Conditional award granted of shares under the LTIP. Maximum number of shares as follows:

1. Lord Wolfson of Aspley Guise - 8,776

2. Jonathan Blanchard - 5,575

3. Richard Papp - 6,504

4. Jane Shields - 6,504

5. Jeremy Stakol - 5,575

6. Marcelle Stakol - 1,014

c)

 

Price(s) and volume(s)

Price(s)

Volume(s)

Lord Wolfson of Aspley Guise

Nil

8,776

Jonathan Blanchard

Nil

5,575

Richard Papp

Nil

6,504

Jane Shields

Nil

6,504

Jeremy Stakol

Nil

5,575

Marcelle Stakol

Nil

1,014

d)

 

Aggregated information

- Aggregated volume

n/a single transactions

- Price

 

 

e)

 

Date of the transaction

 

3 October 2025

f)

 

Place of the transaction

 

Outside a trading venue

 

H Woodall-Pagan

Company Secretary

 

 

 

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.
 
END
 
 
DSHFLFSEIELVIIE
Date   Source Headline
8th Dec 20172:57 pmRNSHolding(s) in Company
6th Dec 20174:32 pmRNSTransaction in Own Shares
5th Dec 20175:48 pmRNSTransaction in Own Shares
4th Dec 20175:01 pmRNSTransaction in Own Shares
30th Nov 20174:33 pmRNSTotal Voting Rights
13th Nov 20174:54 pmRNSTransaction in Own Shares
10th Nov 20175:13 pmRNSTransaction in Own Shares
9th Nov 20175:10 pmRNSTransaction in Own Shares
9th Nov 201711:17 amRNSDirector/PDMR Shareholding
3rd Nov 20173:16 pmRNSHolding(s) in Company
2nd Nov 20171:33 pmRNSHolding(s) in Company
1st Nov 20175:33 pmRNSTransaction in Own Shares
1st Nov 20177:00 amRNSTrading Statement
31st Oct 20174:38 pmRNSTotal Voting Rights
31st Oct 20171:02 pmRNSHolding(s) in Company
2nd Oct 20175:50 pmRNSTransaction in Own Shares
29th Sep 20174:37 pmRNSTotal Voting Rights
28th Sep 20175:29 pmRNSTransaction in Own Shares
27th Sep 20175:59 pmRNSTransaction in Own Shares
26th Sep 20175:36 pmRNSTransaction in Own Shares
20th Sep 20175:33 pmRNSTransaction in Own Shares
19th Sep 20176:29 pmRNSTransaction in Own Shares
15th Sep 201710:57 amRNSDirector/PDMR Shareholding
14th Sep 20177:00 amRNSResults for the Half Year Ending July 2017
31st Aug 20174:30 pmRNSTotal Voting Rights
7th Aug 20172:14 pmRNSDirector/PDMR Shareholding
3rd Aug 20174:57 pmRNSDirector/PDMR Shareholding
3rd Aug 20177:00 amRNSTrading Statement
1st Aug 20175:00 pmRNSBoard Change
31st Jul 20174:05 pmRNSTotal Voting Rights
25th Jul 20179:56 amRNSBlock listing Interim Review
30th Jun 20174:30 pmRNSTotal Voting Rights
29th Jun 20173:35 pmRNSHolding(s) in Company
12th Jun 20173:19 pmRNSHolding(s) in Company
31st May 20174:26 pmRNSTotal Voting Rights
22nd May 20175:49 pmRNSDirector/PDMR Shareholding
18th May 20172:58 pmRNSBoard Change
18th May 20172:22 pmRNSResult of AGM
16th May 20175:27 pmRNSDirector/PDMR Shareholding
8th May 20176:14 pmRNSHolding(s) in Company
4th May 20177:00 amRNSTrading Statement
28th Apr 20174:00 pmRNSTotal Voting Rights
18th Apr 20171:02 pmRNSAnnual Financial Report
4th Apr 20171:36 pmRNSDirector/PDMR Shareholding
31st Mar 20174:30 pmRNSTotal Voting Rights
28th Mar 20175:05 pmRNSDirector/PDMR Shareholding
27th Mar 20173:41 pmRNSDirector/PDMR Shareholding
24th Mar 20172:34 pmRNSDirector/PDMR Shareholding
24th Mar 20171:12 pmRNSFurther re correction to results for year to 2017
23rd Mar 20177:00 amRNSResults for the year ending January 2017

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.